Revisiting the relevance of the 3-month safety period in the evaluation of prosthetic valve endocarditis with FDG-PET/CT
- PMID: 32056103
- DOI: 10.1007/s12350-020-02070-y
Revisiting the relevance of the 3-month safety period in the evaluation of prosthetic valve endocarditis with FDG-PET/CT
References
-
- Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017;58:1341-53. - DOI
-
- Martineau P, Pelletier-Galarneau M, Juneau D, Leung E, Birnie D, Beanlands RSB. Molecular imaging of cardiac sarcoidosis. Curr Cardiovasc Imaging Rep 2018;11:6. - DOI
-
- Pelletier-Galarneau M, Ruddy TD. PET/CT for diagnosis and management of large-vessel vasculitis. Curr Cardiol Rep 2019;21:34. - DOI
-
- Sarrazin J-F, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012;59:1616-25. - DOI
-
- Kim J, Feller ED, Chen W, Dilsizian V. FDG PET/CT imaging for LVAD associated infections. JACC Cardiovasc Imaging 2014;7:839-42. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
